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Abstract
Liver regeneration is vital for graft survival and adequate organ function. Smad activation
regulates hepatocyte proliferation and macrophage function. Aim of the current study is to
evaluate the impact of Smad3 signaling during liver regeneration in the mouse.
Male C57/Bl6 wild type (wt) mice or mice deficient in Smad3 (Smad3−/−) were subjected to a
70% partial hepatectomy (pHx) or sham surgery and sacrificed 24, 42, or 48 hours later. Tissue
was analyzed for TGFβ signaling, the mitogenic cytokine response (i.e. tumor necrosis factor
alpha, TNFα; interleukin (IL) 6), and liver regeneration.
Partial hepatectomy stimulated a strong regenerative response measured by proliferating cell
nuclear antigen positive hepatocytes 42 and 48hr post-pHx in conjunction with elevated
expression of IL6, TNFα and Smad2/3 phosphorylation 24hr post-pHx in both hepatocytes and
non-parenchymal cells. Surprisingly, Smad3 deficiency led to reduced hepatocyte proliferation
42hr post-pHx which recovered by 48hr, a process which correlated with and was preceded by
significant reductions in IL6 expression and signal transducer and activator of transcription 3
phosphorylation, and cyclin D1 induction 24hr post-pHx.
Loss of Smad3 signaling suppresses the expression of key mitogenic cytokines and delays
hepatocellular regeneration. Therapies directed at finely regulating Smad3 activation early within
the regenerating liver may prove useful in promoting liver cell proliferation and restoration of
liver mass.
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Introduction
Liver transplantation remains the primary treatment option for patients suffering from
chronic liver pathologies including cirrhosis and severe acute liver failure. Limited donor
organs have necessitated the use of marginal livers as well as small for size liver grafts
including living donor related transplantation. Transplantation of marginal or reduced size
liver grafts requires regeneration of tissue (1). Limited or impaired regeneration is a major
cause of organ failure following transplantation in these patients (2). Fortunately, the healthy
liver possesses the ability to regenerate as much as 70% of its tissue mass within 14 days
though a variety of factors have been associated with inhibition of this response (3). Indeed,
inflammation associated with ischemic tissue injury, viral infection, and immune-mediated
tissue rejection are known to significantly disrupt the regenerative response (4–6).
Experimentally, the mechanisms of the regenerative response have been evaluated and it is
clear that a number of soluble factors contribute significantly to hepatocyte proliferation and
liver regeneration. For example, inhibited hepatocyte growth factor signaling (7), disrupted
early hepatocyte proliferation (8) and delayed restoration of organ mass increased the
susceptibility of organs to failure. Likewise, loss of normally pro-inflammatory cytokines
including IL6 and TNFα significantly suppressed early hepatocyte proliferation and delayed
organ re-growth. Downstream activation of signal transducer and activator of transcription
(Stat) 3 and nuclear factor kappa B by IL6 and TNFα respectively are critical to the
induction of hepatocyte proliferation and survival following tissue loss (9, 10). Together,
liver regeneration represents an important and highly regulated mechanism of tissue repair
and critical feature for small for size liver grafts.
Counterbalancing the early pro-proliferative genes is the expression and action of
transforming growth factor beta (TGFβ) (11). TGFβ mediated activation of Smad proteins,
particularly Smad2, 3, and 4 (i.e. the inhibitory Smads), upregulates several inhibitors of cell
proliferation including p27kip limiting cellular regeneration in a number of cell lines
including hepatocytes (12). Recent studies have highlighted Smad3 as key intracellular
signaling molecule activated by the TGFβ receptor upon ligation with active TGFβ (13).
TGFβ and associated Smad signaling are known to suppress immune cell function in a
number of experimental models including inflammatory bowel disease (14). Within the
liver, Smad3 activation promotes hepatic stellate cell activation during severe chemical-
induced liver injury and fibrogenesis while also supporting T cell-mediated liver injury
through promotion of hepatocellular apoptosis (15, 16). During liver regeneration, TGFβ
induction is thought to suppress the proliferation of hepatocytes and limit or terminate the
regenerative response (10, 17). The importance of Smad3 in this process has not been
investigated though it was hypothesized that Smad3 activation would limit hepatocyte
regeneration and promote hepatocellular apoptosis following significant tissue loss. To test
this hypothesis, wild type mice or mice deficient in Smad3 were subjected to a partial (70%)
hepatectomy and allowed to recover for up to 48 hours. Surprisingly, absence of Smad3 was
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associated with decreased early hepatocyte proliferation in conjunction with reduced IL6
production and Stat3 activation. These data highlight, for the first time, the ability of Smad3




All animals received humane care according to the criteria outlined in the “Guide for the
Care and Use of Laboratory Animals”. The conduct of the study was approved by the
University Institutional Animal Care and Use Committee. Animals were housed in pathogen
free barrier facilities and had free access to water and diet. Male 10–14 week old wild type
(wt) C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) and mice deficient in Smad3
(Smad3−/−) on a C57Bl/6 background (kindly provided by Dr. Xiao-Fan Wang, Duke
University Medical Center (13), were subject to a 70% partial hepatectomy (pHx) or sham
surgery for control as published previously (4). After 24h, 42h or 48h, mice were sacrificed
and tissue was collected to assess liver damage, cell proliferation, gene expression and
transcription factor activity. In addition, to evaluate the cytokine response in wild type or
Smad3−/− mice, lipopolysaccharide was injected i.p. at a dose of 2.5mg/kg 6 hours prior to
sacrifice. Again, serum and tissue were collected to assess liver injury and the hepatic
cytokine response.
Pathologic Evaluation / Terminal UTP Nick End Labeling (TUNEL) Staining
Livers were fixed in 4% buffered formalin, embedded in paraffin, and stained with
hematoxylin and eosin to assess histopathology. To assess liver cell death, deparaffinized
sections were stained for DNA fragmentation using a commercially available Cell Death
Detection Kit (Roche, Mannheim, Germany) according to the manufacturer’s
recommendations and as previously described (15). Slides were viewed by fluorescent
microscopy and images captured with a digital camera (Olympus DP-70, Center Valley,
PA).
Immunohistochemistry
Immunohistochemistry was performed with minor modifications as reported previously
(18). Deparaffinized liver sections were stained for phosphorylated Smad2 and 3 (pSmad2/3,
Santa Cruz, Santa Cruz, CA). In brief, after proteinase K incubation (20µg/ml) for 5 min
with consecutive blocking for 20 min using 1% bovine serum albumin diluted in phosphate
buffered saline (PBS-1% BSA), sections were incubated with the primary antibody (1:250)
for 1h. After washing in PBS, slides were treated with anti-rabbit HRP-conjugated
secondary antibody (Amersham, Little Chalfent, UK) at a concentration of 1:250 in PBS-1%
BSA. Proliferating cell nuclear antigen (PCNA) and BrdU staining were completed as
previously described (4, 19). Immunocomplexes were visualized using diaminobenzidine
(Dako, Carpenteria, CA) and signals quantified using Image J (NIH image, www.nih.gov).
PCNA quantitation is presented as positive hepatocyte nuclei per 1000 total hepatocytes,
indicated as PCNA labeling index.
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Total RNA Isolation and Real Time Reverse Transcription-PCR
Total RNA was isolated from whole liver using Trizol reagent (Invitrogen, Carlsbad, CA).
Reverse transcription was carried out using Superscript II reverse transcription reagents
(Invitrogen) and random hexamers according to the manufacturers direction. Polymerase
chain reaction was performed using a 170–9740 MyiQ Single-Color Real-Time PCR
Detection System (Biorad, Hercules, CA) according to the manufacturer’s instructions. An
optimal PCR reaction for all investigated genes was established using the LightCycler–DNA
Master SYBR Green I Kit (Roche, Mannheim, Germany). Results were normalized to β-
actin using the comparative cT method. The data are presented as mean ± SEM with the
sequences of the primers used listed in Table 1.
Western blotting
Cellular proteins were extracted as described previously (20) from whole liver and
quantified using a Bio-Rad protein assay (BioRad). Cellular proteins (100µg) were separated
by electrophoresis on 8–16% Tris-glycine gels by SDS-PAGE and electrophoretically
transferred to a nitrocellulose membrane (Amersham). The membranes were blocked using
5% BSA in TTBS (0.1% Tween-20 in 100 mM Tris-HCl pH 7.5, 0.9% NaCl), followed by
incubation with anti-pSmad3, total Smad3, pStat3 and total Stat3, Cyclin D1, and cyclin
dependent kinase 4 (CDK4), respectively (all from Cell Signaling Technologies,
Burlinghame, UK), at 4°C overnight at a dilution of 1:1000. After washing, membranes
were treated with appropriate HRP-conjugated secondary antibody (1:10,000) for 1h at room
temperature. Signals were detected using ECL Western Detection Reagent (Amersham).
Western blots were quantified using Image J (www.nih.gov) and corrected for their proper
control, respectively.
Statistics
Data are presented as the mean ± SEM. The statistical significance of differences between
Smad3-deficient mice and wt control groups was determined by comparison of the mean
using the independent samples T-test. A p value of <0.05 was considered as statistically
significant. Statistical analyses were performed using SPSS 11.0 software (SPSS Inc.,
Chicago, IL).
Results
Smad3 is activated in the Regenerating Murine Liver
To test our hypothesis that Smad3 is activated and therefore might play a role in the
regenerating liver, wt mice were subject to a standardized 70% partial hepatectomy or sham
surgery. Western blotting showed an increase in pSmad 3 24h post-pHx as shown in Figure
1a and quantification of band density (Figure 1b). Additionally, immunohistochemistry of
pSmad 2/3 24h after pHx confirmed the findings of increased phosphorylation of Smad3
which localized to both the nuclei of hepatocytes as well as in non-parenchymal cells in the
regenerating liver (Figure 1c). These data highlight the activation of Smad3 within the
regenerating liver and implicate it in the function of both hepatocytes and non-parenchymal
cell populations.
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Smad3 Promotes Early pHx-Induced Liver Regeneration
TGFβ/Smad activation promotes senescence of hepatocytes late in the regenerative process.
The function of Smad3 specifically in this process has not been evaluated. It was
hypothesized that Smad3 plays a critical intermediary role for connecting TGFβ receptor
binding and inhibition of hepatocellular proliferation. pHx promoted significant
hepatocellular proliferation as early as 24 hours post-pHx which continued to increase at 42
and 48 hours post-pHx as measured by proliferating cell nuclear antigen positive hepatocyte
nuclei (Figure 2a and b). Interestingly, and in contrast to our original hypothesis, Smad3
deficiency reduced hepatocellular proliferation at 42 hours post-pHx as assessed by PCNA+
hepatocyte nuclei (Figure 2a–b). This was further confirmed by reduced bromodeoxyuridine
incorporation, a specific indicator of DNA replication in these cells at 42hr but not 48hr
post-pHx (Figure 2c).
To further evaluate the proliferative response, and confirm immunohistochemical findings,
total tissue protein was isolated from regenerating liver samples and probed for cyclin D1,
CDK4, and PCNA. As shown in Figure 2d, pHx in wild type mice induced cyclin D1
expression at 24hr post-pHx and remained elevated through 48hr post-pHx. Similarly,
CDK4, a key activator of the regenerative process in hepatocytes, was also induced at 24hr
post-pHx and remained elevated through 48hr post-pHx (21, 22). In the absence of Smad3,
induction of CDK4 and cyclin D1 was delayed out to 42 and 48hr respectively. This
inhibition of cyclin D1 expression was further confirmed by immunohistochemistry at 24hr
post-pHx in Smad3-deficient livers when compared to their wild type pHx treated controls
(Figure 2e).
In addition to potentially regulating the regenerative response, TGF/Smad signaling may
also promote hepatocellular apoptosis. Indeed, previous studies by our laboratory
demonstrated the profound importance of Smad3 in regulating hepatocellular apoptosis
following toxin administration (15). To this end, liver sections were evaluated by terminal
UTP nick end labeling (TUNEL) staining to evaluate the apoptotic response in this model of
murine liver regeneration. pHx did not induce significant hepatocellular apoptosis at any
time point examined in either wild type or Smad3-deficient mice (Supplemental Figure 1).
Together, these data highlight the importance of Smad3 signaling in the early regenerative
response following major tissue loss in the mouse.
Smad3 Promotes pHx-induced Cytokine Production
To investigate the underlying mechanism by which Smad3 signaling might influence the
proliferative response in hepatocytes, cytokine expression was assessed by quantitative PCR
for TNFα and IL6, two key pro-inflammatory yet mitogenic cytokines. pHx resulted in
significant increases in both TNFα and IL6, but not TGFβ, at 24 and 42hr post-surgery when
compared to pre-pHx levels (Figure 3). This is consistent with previous studies by our
laboratory demonstrating enhanced mRNA expression of IL6 and TNFα post-pHx (4). Loss
of Smad3 led to a significant reduction in IL6 gene expression 24 hours post-pHx and TNFα
expression 42hr post-pHx when compared to similarly treated wt mice. While these data are
limited to the analysis of gene expression for these factors, they do suggest that Smad3
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signaling interacts with pro-mitogenic cytokine production in the regenerating murine liver
and highlight a potential mechanism for the impaired regenerative response observed.
Role of Stat3 in the Regenerating Liver
To better define the potential impact of disrupted pro-mitogenic cytokine production on the
regenerative response, we focused on the downstream targets of these cytokines, particularly
IL6. Stat3 is a key target and regulator of IL6 signaling in regenerating cells including
hepatocytes (6). Consistently, loss of Stat3 suppresses the regenerative response of
hepatocytes following major tissue loss (23). Given that IL6 expression was reduced, we
sought to determine the impact of this reduction on Stat3 activation. As shown in Figure 4,
Stat3 is activated early during regeneration in the wt liver as indicated by its level of
phosphorylation (24hr post-pHx; Figure 4A) and remains elevated through 48hr post-pHx.
Consistent with reduced IL6 production in Smad3 deficient mice, Stat3 phosphorylation is
impaired in these mice 24hr post-pHx, a time-point preceding the reductions in liver
regenerative response. Stat3 activation recovers, however, at 42 and 48 hours to levels at or
above those seen in similarly treated wt mice.
To further define the interactions of Smad3 signaling and Stat3 regulation, two additional
regulators of the response were quantified. Suppressor of cytokine signaling 3 (SOCS3) and
protein inhibitor of activated stat 3 (PIAS-3) are key regulators of Stat3 activation and
downstream targets of Stat3 activation as well (24, 25). Indeed, both SOCS3 and PIAS-3 are
induced by Stat3 activation and act as negative feedback regulators to suppress Stat3
function. As shown in Figure 4C, SOCS3 expression is strongly elevated in wt mice 24
hours post-pHx and remains elevated through 48hr post-pHx consistent with the continued
activation state of Stat3 in these livers. Figure 4D further confirms the induction of a
negative regulator of Stat3 activation, PIAS-3, at 24hr post-pHx in wt mice when compared
to pre-pHx levels. Interestingly, and consistent with impaired Stat3 activation, both SOCS3
and PIAS-3 were not induced in Smad3-deficient livers when compared to similarly treated
wt mice at 24 or 42hr post-pHx. Together, these data demonstrate reduced Stat3 activation
in the Smad3 deficient liver, a process occurring independent of the induction of potential
negative regulators of the response, and further suggesting an important connection between
Smad3 and IL6 production in the regenerating liver.
Smad3 promotes Endotoxin-induced hepatic IL6 production
It is clear from these studies that Smad3 signaling affects key pro-mitogenic cytokine
production, Stat3 activation, and hepatocellular regeneration early during the regenerative
response to pHx. Interestingly, immunohistochemistry reveals Smad3 activation, as assessed
by its phosphorylation, both in parenchymal and non-parenchymal cells during this early
period of regeneration. Kupffer cells (KC), the hepatic macrophage, contribute to
inflammatory cytokine production in acute and chronic liver injuries (26). KCs also play a
substantive role in liver regeneration, as their loss prolongs the time to restoration of tissue
mass (27). The influence of Smad3 activation on hepatic KC responses has not been
thoroughly investigated though it is thought that TGFβ-mediated activation of Smad3 likely
suppresses their function. As KCs may be a significant contributor to IL6 production in the
liver, we sought to address the function of Smad3 in their production of this important pro-
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proliferative cytokine (27). As shown in Figure 5, lipopolysaccharide (LPS) administration 6
hours prior to sacrifice does not induce significant TGFβ mRNA synthesis but promotes
strong IL6 and TNFα production in conjunction with CD14 expression consistent with
numerous previous reports (28). Loss of Smad3 does not affect CD14 induction or alter the
TGFβ response but completely blocks IL6 production and limits TNFα mRNA synthesis in
response to LPS suggesting that KCs are impaired in their synthesis of key pro-
inflammatory but also pro-proliferative mediators in response to a common endogenous
activator. These data implicate Smad3 signaling in the regulation of IL6 production by liver,
and likely by KCs, and may suggest a potential mechanism by which Smad3 signaling
positively regulates early regenerative responses in the hepatectomized animals.
Discussion
The balance between cell proliferation and apoptosis is vital for tissue homeostasis but also
regeneration that depends on several growth factors and cytokines (9). Upon binding of
TGFβ to its type I and II surface receptor complexes, intracellular Smad2 and 3 are
phosphorylated and form a complex with Smad4, which translocates to the nucleus to
modulate the transcriptional response by interacting with a variety of factors regulating the
expression of target genes (29). Intriguingly, while Smad2 and 4 are required for
development, Smad3 function appears dispensable given the survival and health of rodents
deficient in its expression (30). Accumulating data would suggest that this factor may be
more centrally responsible for regulation of the inflammatory response with redundant
developmental support provided by other inhibitor Smads (31–33). This led us to investigate
its function in the regenerating liver, where both cellular regeneration and inflammatory
responses converge to promote a regulated and balanced restoration of liver mass.
Surprisingly, and in contrast to our original hypothesis, global deletion of Smad3 impaired
hepatocellular regeneration and interrupted key early IL6 induction and Stat3 activation
within the murine liver.
TGFβ and Hepatocyte Regeneration
TGFβ and Smad signaling is associated with cell cycle arrest and is also known to be an
inducer of apoptosis (34). TGFβ is significantly increased in regenerating human
transplanted livers and likely contributes to cessation of liver growth. Experimentally,
overexpression of TGFβ inhibits the proliferative response of hepatocytes following major
tissue loss while loss of TGFβ receptor 2 promotes early mitogenic reflexes within
hepatocytes. Studies by Zhong and colleagues have confirmed this relationship
demonstrating an enhancement in liver regeneration characterized by increased graft size
and BrdU incorporation in transplanted rat livers overexpressing Smad7 in conjunction with
reduced nuclear Smad2/3 translocation (19). It was therefore hypothesized that loss of
Smad3, a key signaling element within the TGFβ cascade, would also promote hepatocyte
regeneration following partial hepatectomy similar to that seen in TGFβR2 deficient or
Smad7 over-expressing livers. Surprisingly, loss of Smad3 reduced early replicative
responses in regenerating hepatocytes within the murine liver. Analysis of both PCNA+
hepatocytes and BrdU incorporation revealed significantly reduced proliferation at 42 hours
post-pHx in conjunction with impaired cyclin D1 and CDK4 expression at 24hr post-pHx.
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Intriguingly, hepatocellular proliferation rebounded and overshot the wild type response by
48 hours post-pHx consistent with previous studies characterizing the TGFβ effect and
suggesting apparent dueling effects of TGF-Smad3 signaling in the context of liver
regeneration, possibly through differential effects on different hepatic cell populations.
Indeed, our studies stop short of defining a cell specific effect of TGFb-Smad3 signaling
though separate approaches do define a potential disruption in KC in Smad3-deficient mice.
TGFβ signaling and Kupffer cell Function
It is clear that TGFβ plays an important role in non-parenchymal cell function within the
liver. Interruption of TGFβ signaling within lymphocytes promotes hepatocellular injury and
autoimmune-like hepatitis while this same signaling pathway promotes stellate cell
activation and expression of type I collagen (16, 35). TGFβ has also been shown to inhibit
pro-inflammatory cytokine production in Kupffer cells in conjunction with their transition
toward a more regulatory phenotype (36). Within the current study, loss of Smad3 signaling
suppressed IL6 and TNFα production following stimulation with LPS in vivo suggesting a
potential defect in this response as a mechanism for the delayed regenerative response
observed. Studies in our laboratory support a similar role for TGFβ and Smad3 in the
induction of TNFα production by hepatic macrophages (Son and Hines, unpublished
observation). Administration of TGFβ to hepatic macrophages promoted TNFα production
in response to Tlr4 engagement while loss of Smad3 or overexpression of Smad7 suppressed
this response. The connection between Smad3 and IL6 production remains unclear. Nath
and colleagues recently demonstrated reduced IL6 production in ischemic kidney injury in
Smad3-deficient mice (37). IL6 is regulated by a number of factors including nuclear factor
kappa B (NFκB), NF-IL6, Fos-Jun, and CAAT/enhancer binding protein (C/EBP) (38).
Likewise, soluble mediators including TNFα and IL1 have also been shown to promote its
transcription. TGFβ is known to interact with a number of these pathways with its effects
being at least partly cell specific. Aoki and others demonstrated the ability of pancreatic
stellate cells to produce IL6 in response to TGFβ stimulation in vitro, and the coordinate up-
regulation of TGFβ in response to IL6 treatment suggesting autocrine loop to promote
expression of both (39). Further investigation in bronchial epithelial cells revealed the ability
of TGFβ to promote IL6 production, a process which was related to c-Jun N terminal kinase
(JNK) activation (40). Activation of NFκB by TGFβ also promotes epithelial to
mesenchymal transition (EMT) defining a connection for these signaling pathways (41).
Within macrophages, TGFβ signaling in part through the co-receptor endoglin promotes
their recruitment and cytokine production, specifically IL1β and IL6, in radiation-induced
kidney damage (42). Similarly, in osteoclasts, TGFβ mediated activation of TGF activated
kinase 1 (TAK1) promoted Akt activation and subsequent NFκB induction leading to cell
survival (43). Thus, it appears that TGFβ-mediated responses may promote inflammatory
transcription factor activation and support IL6 production among other cytokines and have
potentially pro-proliferative roles in the regenerating murine liver.
TGFβ-Smad3 and the Regenerative Response – Is the IL6-Stat3 axis the connection?
Within the current study, it is clear that Smad3 signaling promotes IL6 production in the
regenerating liver, possibly from hepatic KCs, and this induction correlates with hepatic
Stat3 activation and cell proliferation. In the liver, IL6 is a major regulator of the acute
Kremer et al. Page 8






















phase response, and promotes early liver regeneration (10, 44). Fausto and others
demonstrated elevated IL6 early during the regenerative response, a process which was
preceded by and associated with TNFα induction (10, 45). Additional experiments using Il6
and TNFα receptor 1 (TNF-R1) knockout mice after pHx demonstrated an impaired S phase
progression with defects in hepatocyte proliferation and high mortality rate. In both IL6 and
TNFα-R1 knockout mice, the blunted regenerative response could be rescued by treating the
animals with IL6 (44). Conversely, overexpression of IL6 has been shown to inhibit the
proliferative capacity of hepatocytes within the regenerating liver likely owing to its ability
to act as a potent inflammatory mediator and highlighting the importance of a fine tuned
pro-proliferative cytokine response during the restoration of lost liver mass (46). The current
study has demonstrated an interaction between Smad3 signaling and pro-proliferative
cytokine production IL6 and the downstream activation of Stat3. Stat3 signaling is a known
regulator of cell survival and proliferation (6). Upon activation by a number of factors
including IL6, Stat3 promotes cell survival including induction of anti-apoptotic factors
while also promoting cell cycle progression and liver regeneration (23, 47). In support of
this notion are studies which show that loss of Stat3 in hepatocytes reduced their
proliferation early during regeneration following partial hepatectomy and to a similar degree
following carbon tetrachloride induced liver damage (6, 23, 47). Connectivity between Stat3
and Smad3 has also been shown previously. Wierenga and colleagues showed a reduction in
IL6-mediated Stat3 activation in the presence of TGFβ in leukemia cells, a process which
involved interruption of JAK activation and induction of cellular apoptosis (48). In contrast,
induction of protein inhibitor of activated Stat3 (PIAS3), a factor induced by Stat3
activation, significantly increased TGFβ-mediated Smad3 activation suggesting that TGFβ-
Smad signaling could be a negative feedback loop to inhibit Stat3 mediated proliferative
signals (49). Within the current study, a new connection can be drawn between TGFβ-
Smad3 signaling, IL6 production, downstream Stat3 activation, and early hepatocellular
regeneration in the hepatectomized liver. It is likely that the net effect of loss of Smad3 early
during regeneration is interruption of IL6 production independent of interactions between
Smad3 and Stat3 signaling pathways. However, TGFβ mediated Smad3 activation could
limit later Stat3 activation in hepatocytes independent of alterations in IL6 induction as Stat3
activation is strongly and significantly increased at 42hr post-pHx in Smad3−/− livers when
compared to similarly treated wild type mice. The current study is limited in this regard with
respect to understanding the cell specific effects of a loss of Smad3 throughout the
regenerative response though it is clear that TGFβ-mediated Smad3 activation provides both
pro-proliferative and potentially inhibitor signals during liver regeneration. In sum, however,
the current studies do draw a connection between Smad3, IL6 production, and early
hepatocellular regeneration following major tissue loss in the mouse but do remain limited
in directly defining the cell specific impact of this signaling molecule on IL6 production and
liver regeneration.
Conclusion
Understanding the mechanisms of tissue repair and regeneration, particularly following
major tissue loss, is critical to defining new treatments to extend or promote organ survival
clinically. Early regenerative efficiency, especially within the first 48 hours post-surgery, is
critical for graft and recipient survival. Great strides have been made to better define
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characteristics favorable for organ survival, both with the organ itself as well as the
recipient. The current study highlights Smad3 signaling as a potential, and surprising,
positive regulator of IL6 production and hepatocellular proliferation during this critical early
period of liver regeneration. These studies are no doubt limited, however, in that the cell
specific effects of TGFβ and Smad activation remain unresolved. Recent generation of
floxed alleles associated with TGFβ and TGFβ associated signaling will provide the
technical framework to assess these processes more specifically. Nevertheless, the current
results implicate components of TGFβ signaling in the induction of pro-proliferative
responses and provide potential new targets for regulation of hepatocellular regeneration.
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Smad3 is activated early within the regenerating liver. Wild type mice were subjected to
partial (70%) hepatectomy. Phosphorylated Smad3 was then examined by (A) western blot
with (B) quantification of band density and (C) immunohistochemistry for pSmad3 at the
indicated time-points. Representative data are presented from 4–6 animals per group.
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Smad3 signaling promotes early proliferation within the murine liver. Wild type (WT) or
Smad3-deficient mice were subjected to partial (70%) hepatectomy and allowed to recover
for 24, 42, or 48 hours. (A) PCNA immunohistochemical analysis of liver sections from
various time-points post-pHx. Representative photomicrographs at 200× magnification from
indicated time-points. (B) Quantitation of positively stained cells from indicated time-points.
Data presented as PCNA labeling index, quantified as positive hepatocyte nuclei per 1000
hepatocytes. (C) Bromodeoxyuridine incorporation 24, 42, or 48 hours post-pHx in WT or
Smad3−/− mice. (D) Western blot analysis of cyclin D1 and CDK4 protein expression 0, 24,
42, or 48hr post-pHx with representative immunoblot presented. Coomassie stained gel
provided to demonstrate loading equality. (E) Cyclin D1 immunohistochemistry 24 hours
following pHx in WT or Smad3-deficient liver sections. Specific staining in (A), (C), and
(E) appears as brown to black. *p<0.05 vs. time-matched wild type (WT) mouse with 3–6
mice per group.
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Smad3 signaling promotes IL6 expression within the regenerating liver. Wild type or
Smad3-deficient mice were subjected to partial (70%) hepatectomy for up to 48 hours. Gene
expression for tumor necrosis factor alpha (TNFα), interleukin 6 (IL6) and transforming
growth factor beta (TGFβ) were then quantified at indicated time-points by real time PCR.
n=4–6 animals per group. * p<0.05 vs. time-matched wild type (WT) control.
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Absence of Smad3 signaling inhibits Stat3 activation within the regenerating liver. Wild
type or Smad3-deficient mice were subjected to partial (70%) hepatectomy and Stat3
activation evaluated at 0, 24, 42 or 48 hours post surgery. (A) Representative blot of
phosphorylated Stat3 (pStat3) and total Stat3 24 hours following hepatectomy in wild type
and Smad3-deficient mice. (B) Quantification of Stat3 activation 0, 24, 42, or 48 hours
following hepatectomy. (C) Hepatic PIAS3 and (D) SOCS3 gene expression 0, 24, 42, or 48
hours post-pHx as assessed by quantitative PCR. n=3 animals per group.
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Loss of Smad3 reduces endotoxin-elicited IL6 and TNFα production but not CD14
expression in the murine liver. Wild type or Smad3−/− mice were administered
lipopolysaccharide (LPS; 2.5mg/kg) or saline by intraperitoneal injection 6 hours prior to
sacrifice. Tissue expression for IL6, TNFα, TGFβ, and CD14 was determined by
quantitative PCR. n=4–6 animals per group.
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Table 1
Primer list for quantitative PCR measurements







β actin 5’-AGGTGTGCACCTTTTATTGGTCTCAA-3’ 5’-TGTAGTAAGGTTTGGTCTCCCT-3’
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